Key Metrics
CiteScore 

3.9
Eigenfactor 

0.01 - 0.05
Impact Factor 

5 - 10
SJR 

Q2Strategy and Management

SNIP 

3.1
Recommended pre-submission checks
Powered by 

Harvard Business Review Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | HARVARD BUSINESS SCHOOL PUBLISHING CORPORATION |
| Language | English |
| Frequency | Monthly |
| General Details |
View less
Planning to publish in Harvard Business Review ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Harvard Business Review
WISP-3 enhances proinflammatory cytokine IL-1β production in rheumatoid arthritis through the FAK, JNK and AP-1 pathways.
- 1 Jul 2026
- Cellular immunology
UVB induces DNA hypomethylation and cell activation in CD4+ T cells of systemic lupus erythematosus via miR-410 regulating GADD45A.
- 1 Jul 2026
- Cellular immunology
Armed oncolytic adenovirus elicits a "self-feeder" effect to supercharge NK cells for solid tumor control.
- 1 May 2026
- Cellular immunology
FGF20 alleviates neuroinflammation in ischemic stroke by modulating microglial polarization via TREM2-TLR4/NF-κB pathway.
- 1 May 2026
- Cellular immunology
Tumor resection may abort the antitumor immune response produced from primary foci.
- 1 May 2026
- Cellular immunology
MFG-E8 inhibits AT1-AA production to alleviate preeclampsia.
- 1 Apr 2026
- Cellular immunology
WISP-3 enhances proinflammatory cytokine IL-1β production in rheumatoid arthritis through the FAK, JNK and AP-1 pathways.
- 1 Jul 2026
- Cellular immunology
UVB induces DNA hypomethylation and cell activation in CD4+ T cells of systemic lupus erythematosus via miR-410 regulating GADD45A.
- 1 Jul 2026
- Cellular immunology
Armed oncolytic adenovirus elicits a "self-feeder" effect to supercharge NK cells for solid tumor control.
- 1 May 2026
- Cellular immunology
FGF20 alleviates neuroinflammation in ischemic stroke by modulating microglial polarization via TREM2-TLR4/NF-κB pathway.
- 1 May 2026
- Cellular immunology
Tumor resection may abort the antitumor immune response produced from primary foci.
- 1 May 2026
- Cellular immunology
MFG-E8 inhibits AT1-AA production to alleviate preeclampsia.
- 1 Apr 2026
- Cellular immunology